Fmr LLC Has $181,000 Stock Position in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Fmr LLC raised its holdings in VanEck Pharmaceutical ETF (NASDAQ:PPHFree Report) by 12.5% during the third quarter, HoldingsChannel reports. The firm owned 1,905 shares of the company’s stock after acquiring an additional 212 shares during the quarter. Fmr LLC’s holdings in VanEck Pharmaceutical ETF were worth $181,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of the business. Thrivent Financial for Lutherans bought a new stake in shares of VanEck Pharmaceutical ETF during the 2nd quarter valued at approximately $16,088,000. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management acquired a new stake in VanEck Pharmaceutical ETF in the third quarter valued at approximately $8,743,000. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of VanEck Pharmaceutical ETF by 51.3% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 248,473 shares of the company’s stock worth $23,565,000 after buying an additional 84,273 shares during the last quarter. Adamsbrown Wealth Consultants LLC acquired a new position in shares of VanEck Pharmaceutical ETF during the third quarter worth $7,030,000. Finally, Bricktown Capital LLC bought a new position in shares of VanEck Pharmaceutical ETF in the 2nd quarter valued at $5,904,000.

VanEck Pharmaceutical ETF Stock Down 0.5 %

NASDAQ PPH opened at $86.54 on Friday. The company has a market cap of $639.53 million, a price-to-earnings ratio of 21.04 and a beta of 0.72. VanEck Pharmaceutical ETF has a twelve month low of $79.95 and a twelve month high of $99.51. The business’s fifty day moving average is $90.24 and its 200 day moving average is $92.87.

VanEck Pharmaceutical ETF Company Profile

(Free Report)

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.

Further Reading

Want to see what other hedge funds are holding PPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for VanEck Pharmaceutical ETF (NASDAQ:PPHFree Report).

Institutional Ownership by Quarter for VanEck Pharmaceutical ETF (NASDAQ:PPH)

Receive News & Ratings for VanEck Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.